Case Report: Occupationally Related Recurrent Varicella (Chickenpox) in a Hospital Nurse by Ku, Chih-Hung et al.
 
Case Report: Occupationally Related Recurrent Varicella
(Chickenpox) in a Hospital Nurse
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Ku, Chih-Hung, Yu-Tien Liu, and David C. Christiani. 2005. Case
Report: Case report: occupationally related recurrent varicella
(chickenpox) in a hospital nurse. Environmental Health
Perspectives 113(10): 1373-1375.
Published Version doi://10.1289/ehp.7766
Accessed February 19, 2015 8:33:51 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:7349724
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAAVaricella (chickenpox), a common contagious
disease of childhood, is caused by the varicella
zoster virus (VZV) [Centers for Disease
Control and Prevention (CDC) 2005]. VZV
is characteristic of the alpha herpes viruses and
establishes latency in the cells of the dorsal
root ganglia after primary infection (Arvin
1996). The etiology of varicella and herpes
zoster was first reported by von Bo´kay in
1888 from the observation that susceptible
children often developed varicella after expo-
sure to adults with herpes zoster (Arvin 1996;
CDC 2005; von Bo´kay 1909). Varicella
results from the primary VZV infection,
whereas herpes zoster (shingles) is the result of
reactivation (Arvin 1996; CDC 2005; Jumaan
etal. 2002). Primary varicella infection usually
results in lifetime immunity (CDC 2005),
and second episodes of varicella are uncom-
mon (CDC 2005; Gershon etal. 1984), but
they may occur (CDC 2005). VZV disease
history always indicates that varicella is the
primary infection, and herpes zoster is a recur-
rence of the disease (Arvin 1996; CDC 1996,
1997, 2005; Gershon etal. 1984; Jumaan
etal. 2002), as well-documented second
episodes of varicella are rare (Gershon etal.
1984). Here we report a case of apparent
VZV reinfection with recurrent varicella infec-
tion in a nurse in a teaching general hospital
in Taiwan. 
Case Presentation
A 25-year-old nurse, who had childhood
chickenpox, was diagnosed with varicella with-
out mention of complication [International
Classification of Diseases, Revision 9 (ICD-9)
code 052.9; World Health Organization
(WHO) 2001] by a dermatologic physician
in a teaching general hospital after she cared
for a 62-year-old male paraparesis patient
who developed herpes zoster during hospitali-
zation. She graduated from nursing school in
July 2001, passed the licensing board, and
then started to work in the neurologic surgery
ward of a general teaching hospital in Taipei,
Taiwan.
Toward the end of June, we conducted a
study of occupational VZV hazards to health
care workers in this hospital. The nurse was
one of the volunteers who carried an air sam-
pler for several hours in rotation with her col-
leagues on 9 July 2002. Saliva was collected
simultaneously. Nested polymerase chain reac-
tion (PCR) VZV DNA results were negative
both in the personal air samples and in saliva. 
On 13 July 2002, a 62-year-old man was
sent to the emergency room due to paraparesis
after he received Chinese traditional chiro-
practic treatment from a nonprofessional. He
was diagnosed with spondylitis with a T8
compression fracture and T9 myelopathy, sus-
pected tuberculosis (TB) of the spine, and
paraparesis and was transferred to a neurologic
(internal medicine) ward in the evening. The
next day he underwent surgery for total
laminectomy (from T8 to T9) and hook sys-
tem (from T6 to T11), and was sent to the
surgical intensive care unit (SICU) for 5 days.
On 18 July 2002, the patient was transferred
to the neurologic surgery ward where the
nurse worked. 
Because the patient was suspected of hav-
ing TB of the spine, he underwent pleural
and video-assisted thoracoscopic surgery
(VATS) biopsy on 1 August. According to
the nurse’s observation, the patient was wor-
ried, anxious, and under a great deal of stress
regarding his health because his income was
the primary financial resource of his family.
On 3 August, multiple pruritic rash and vesi-
cles were found over the patient’s abdomen
and lower back ﬂank area. Herpes zoster was
conﬁrmed by a dermatologic physician. 
During the patient’s hospitalization in the
neurologic surgery ward, the nurse attended
the patient for several days (on 19–22 July,
29 July, 31 July–1 August, and 4–5 August
2002) before she resigned from the job on
12 August. Her regular nursing care tasks
included measuring body temperature, blood
pressure, and pulse; administering medicine;
asking how the patient was feeling; and help-
ing the patient to change his bed rest position. 
At the age of 5 years, the nurse had been
infected with chickenpox by her kindergarten-
age sister, who herself was previously infected
by her kindergarten classmates. At that time,
the nurse, her sister, and her brother had mul-
tiple chickenpox vesicles on their faces simul-
taneously. Because of her previous chickenpox
history, it was supposed that the nurse was
immune to the VZV; while caring for the
patient, she did not wear gloves, a mask, or an
isolation gown before the herpes zoster was
conﬁrmed. 
Because she had passed the admission
examination for graduate study in a medical
school, the nurse planned to resign her job to
become a full-time student by 15 August.
Before she resigned, she took a short vacation
to her hometown in Ping-Tung County, in
the south of Taiwan, on 6 August. However,
on 8 August, she developed a high fever
(39.5°C, 103.1°F), malaise, and headache. She
went to a private clinic and was diagnosed with
influenza by a physician in her hometown.
The next day, in addition to the prodromal
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Research | Environmental Medicinesymptoms, pruritic rash started to appear on
her face, neck, and trunk. She came back to
the teaching general hospital in Taipei on 9
August and was diagnosed with varicella with-
out mention of complication (ICD-9 code
052.9) by another dermatologic physician (not
the herpes zoster patient’s dermatologic physi-
cian). The nurse received treatment with
Allegra (fexofenadine, 60 mg twice per day;
Hoechst, Kansas City, MO, USA), chlorpheni-
ramine (4 mg three time per day; Mine Ta
Chemistry Pharmacy Co., Ltd., Tai Chung,
Taiwan), and Scanol (acetominophen, 500 mg
three times per day; Scanpharm, Birkerød,
Denmark) for 14 days. Because her clinical
symptoms were very clear, no laboratory con-
ﬁrmation testing was performed at that time.
However, to confirm this second varicella
episode before reporting this case, we invited
the nurse to take serologic tests for varicella
antibody on 4 April 2005. The results indi-
cated that VZV-specific IgM was negative
[< 1:20; Meriﬂuor VZV IgM indirect ﬂuores-
cent antibody, (IFA); Meridian Bioscience
Inc., Cincinnati, OH, USA], but the VZV
IgG was positive (1:80 on the basis of > 1:10,
Meriﬂuor VZV IgG IFA), with high sensitivity
(93.9% for IgM and 100% for IgG) and high
speciﬁcity (100% for both antibodies) accord-
ing to the manufacturer’s instructions.
Negative speciﬁc serum IgM and positive
specific serum IgG indicated a past VZV
infection. Because varicella and herpes zoster
both resulted from the same antigen, the
VZV IgG-positive reaction was excluded
from the herpes zoster. It was also excluded
because the nurse did not get herpes zoster
from the second episode of varicella on
9 August 2002 to 4 April 2005. The nurse is
now convalescing.
Discussion
The nurse was diagnosed with an acute
chickenpox infection by a dermatologic
physician at the teaching general hospital on
the basis of her clinical symptoms and signs,
including a high fever (39.5°C), malaise, and
headache prior to the rash appearing on her
face, neck, and trunk. The duration of the
high fever and rash were 5 and 14 days,
respectively. Fever and malaise may appear
1–2 days before rash onset in chickenpox pri-
mary infections in adults, whereas rash is usu-
ally the first sign of the disease in children
(CDC 2005). According to the CDC case
classification (Jumaan etal. 2002), a con-
ﬁrmed case is deﬁned as one that is conﬁrmed
by laboratory testing or that meets the clinical
case deﬁnition and is epidemiologically linked
to a confirmed or a probable case (Jumaan
etal. 2002). Recently, negative speciﬁc serum
IgM and positive specific serum IgG indi-
cated a past VZV infection. The nurse did
not get herpes zoster from the second episode
of varicella on 9 August 2002 to 4 April 2005.
Our case matches both deﬁnitions because the
vesicular illness preceded acute onset with dif-
fuse maculopapulovesicular rash and without
other apparent cause (Jumaan etal. 2002), and
it was epidemiologically linked to the care of a
conﬁrmed herpes zoster patient. 
The air sampling study was performed on
9 July 2002 in the neurologic surgery ward,
and the paraparesis patient was admitted to
the hospital on 13 July 2002 and transferred
to the neurologic surgery ward on 18 July
2002. The patient’s rash was ﬁrst reported on
3 August 2002. It is not surprising that the air
sampling result was negative. In addition, it is
unlikely that the nurse was infected from the
air sampling equipment because the assem-
bled cassettes and sampling pump with tub-
ing were put in a laminar flow unit with
ultraviolet light for 8 hr before sampling, and
sampled cassettes were replaced with a new
assembled cassette every day. 
To investigate this uncommon case, we
considered four parameters: the agent (VZV),
infectious routes, the host (the nurse), and the
hospital environment (hospital ward). 
Agent. Previous reports have mentioned
the same etiology of varicella and herpes
zoster (Arvin 1996; CDC 2005; von Bo´kay
1909). In 1925, children without varicella
history developed varicella after being inocu-
lated with fluid recovered from the herpes
zoster lesions (infectious virus), which
demonstrated the transmissibility of the agent
(Arvin 1996; Kundratitz 1925). In the pre-
sent case, the nurse developed a recurrence of
varicella after nursing a herpes zoster patient,
although she had been infected by her sister
when she was 5 years of age.
Varicella has been reported as the disease
most commonly confused with smallpox
(Jumaan etal. 2002); however, smallpox was
eradicated from Taiwan in 1955 (Center for
Disease Control, Taiwan 2004a, 2004b), and
the routine smallpox vaccination program in
Taiwan ended in 1979 after the disease was
eradicated worldwide following the WHO
campaign (BiotechEast 2003; Center for
Disease Control, Taiwan 2004a, 2004b; Lee
2003). Because the nurse was born in 1978, it
is extremely unlikely that her rash at 5 years
of age was smallpox. 
New variants of VZV have been reported
recently, including VZV-MSP, isolated in St.
Paul–Minneapolis, MN (Santos etal. 1998,
2000), and VZV-BC, isolated in British
Columbia (Tipples etal. 2002). We do not
know whether there is a mutant strain of
VZV in Taiwan; thus this is a good index case
for further study. Another consideration is
that the nurse’s immunity was insufficient
against the second VZV attack, since she was
infected initially over 20 years earlier by her
sister. Unfortunately, it was not possible to
check her VZV antibody titers before her
recurrent varicella episode. 
Infection routes and incubation period. It
has been documented that cases of herpes
zoster are the infectious sources of chickenpox
in susceptible persons (Arvin 1996; CDC
2005). VZV is transmissible by respiratory
routes (Arvin 1996; CDC 2005). Possible
infection routes while the nurse was caring for
the patient included communicating with the
patient and helping the patient change his bed
rest position without employing protection
such as a mask or gloves.
Previous PCR research showed that VZV
is transmissible for 24–48 hr before rash onset,
which is consistent with epidemiologic evi-
dence (CDC 2005; Koropchak etal. 1991), or
4–5 days after a rash appears (CDC 2005). 
The chickenpox incubation period is from
14 to 16 days after exposure (Arvin 1996;
CDC 2005), with a range of 10–21 days
(CDC 2005). In this case, the paraparesis
patient had the rash on 3 August 2002. The
nurse had cared for him on 31 July and on 1,
4, and 5 August. The most likely infection
dates of this episode are 31 July and 1 August,
since the rash appeared on the nurse’s face,
neck, and trunk on 9 August, which is within
the range of 10 days. In addition, recent VZV-
IgG serologic tests indicated that the antibody
titer is still high (1:80 on the basis of 1:10 of a
positive criterion). This method was simple
and highly sensitive and allowed for the rapid
and reliable determination of immunity to
VZV (Sauerbrei etal. 2004). Because varicella
and herpes zoster resulted from the same anti-
gen, VZV, the VZV IgG-positive reaction was
excluded from herpes zoster. It was also
excluded because the nurse did not get herpes
zoster from the second episode of varicella on
9 August 2002 to 4 April 2005.
Host. In addition to a lack of protection
(gloves, mask) while caring for the patient,
stress may be another important host factor
contributing to recurrence. The nurse reported
that before she resigned from the hospital, she
felt stress both from the nursing practice and
the logistics of her resignation, as well as anxi-
ety about her impending study in graduate
school. In fact, during our study of occupa-
tional VZV hazards to healthcare workers in
early July 2002, the nurse reported perfor-
mance anxiety about graduate school and stress
from multiple clinical duties and logistic mat-
ters concerning her resignation, such as the fact
that she was on duty on the date of graduate
school registration, 5 August 2002. According
to the nurse’s own report after the recurrence,
we believe that stress played an important role
in this recurrent varicella.
Environment. Documented environ-
mental VZV DNA included sampling from
the air of the active patient’s room (Sawyer
etal. 1994), or the active patient’s family,
Ku et al.
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sion remote control, and door handle (Asano
et al. 1999). In our study, 20.5% of the 44 air
samples from different departments of the
same hospital were VZV DNA positive. VZV
is highly temperature sensitive (inactivated at
56–60°C) in the environment and is not
infectious if the virion’s envelope is disrupted
(Arvin 1996). The temperature in the hospi-
tal was controlled by the central operation
department at about 25°C. 
The nurse was a young and unmarried
female, with only one year of work history.
Her disease appears to be recurrent varicella,
which is very uncommon, and it appears to be
occupationally related. Documented VZV
infection may cause significant morbidity or
mortality, affecting the mother, the fetus, or
the newborn (Arvin 1996; CDC 1996, 1997,
2005; Harger etal. 2002; Jumaan etal. 2002),
as well increasing the risk of premature delivery
when infected during late pregnancy (Arvin
1996; Paryani and Arvin 1986). We report this
case to emphasize that a varicella infection his-
tory may not be sufﬁcient for determination of
VZV immunity, contrary to the common
belief that a reliable history of varicella is a
valid measure of immunity because the rash is
distinctive and subclinical cases rarely occur
(CDC 1996, 2005; Jumaan etal. 2002). We
think that VZV antibody testing may be neces-
sary for health care workers, especially for new
female workers.
Documented methods of VZV antibody
detection include complement ﬁxation, IFA,
fluorescent antibody to membrane antigen
(FAMA), neutralization, indirect hemaggluti-
nation, immune adherence hemagglutination,
radioimmunoassay, latex agglutination, and
enzyme-linked immunosorbent assay (CDC
1996). Although IFA, FAMA, neutrilization,
and radioimmunoassay have been reported to
be sensitive but time consuming (CDC 1996),
a highly sensitive, speciﬁc, and rapid IFA test
using VZV-infected A549 cells as antigen has
been developed (Sauerbrei etal. 2004). The
sensitivity and the specificity of this method
are 100%, compared to the FAMA test, with
the lowest limit of detection 50 mIU/mL ver-
sus 250 mIU/mL anti-VZV IgG for IFA and
FAMA, respectively (Sauerbrei etal. 2004).
Conclusion
Occupational VZV hazards exist in the health
care environment. The traditional concept of
VZV lifetime immunity after the primary
varicella infection may not be appropriate in a
health care setting. We suggest checking sero-
logic titers for VZV antibody, followed by a
VZV vaccination for nonimmune health care
workers.
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